BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection

Peptides

Volumn 29, Issue 7, 2008, Pages 1118-1123

  Orlando, Fiorenza ^a   Ghiselli, Roberto ^b   Cirioni, Oscar ^b   Minardi, Daniele ^b   Tomasinsig, Linda ^c   Mocchegiani, Federico ^b   Silvestri, Carmela ^b   Skerlavaj, Barbara ^c   Riva, Alessandra ^b   Muzzonigro, Giovanni ^b   Saba, Vittorio ^b   Scalise, Giorgio ^b   Zanetti, Margherita ^c,d   Giacometti, Andrea ^b  

^a INRCA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

^d Natl Lab CIB   (Italy)

Author keywords

Animal model; Biofilm; Cathelicidins; Gram positive cocci; Ureteral stent

Indexed keywords

ANTIINFECTIVE AGENT; BMAP 28; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BIOFILM; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENTEROCOCCUS FAECALIS; FEMALE; GRAM POSITIVE COCCI; NONHUMAN; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS AUREUS; URETER STENT;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PROTEINS; RATS; RATS, WISTAR; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STENTS; URETER; VANCOMYCIN;

ANIMALIA; BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS; POSIBACTERIA; RATTUS; STAPHYLOCOCCUS AUREUS;

EID: 44649096832     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.03.005     Document Type: Article

References (31)

1. Barros M., Martinelli R., and Rocha H. Experimental supratrigonal cystectomy. Evaluation of long term complications. Int Braz J Urol 32 (2006) 350-354
2. Beiko D.T., Knudsen B.E., Watterson J.D., Caadieux P.A., Reid G., and Denstedt J.D. Urinary tract biomaterials. J Urol 171 (2004) 2438-2444
3. Benincasa M., Skerlavaj B., Gennaro R., Pellegrini A., and Zanetti M. In vitro and in vivo antimicrobial activity of two alpha-helical cathelicidin peptides and of their synthetic analogs. Peptides 24 (2003) 1723-1731
4. Buck M.A., Olah T.A., Weitzmann C.J., and Cooperman B.S. Protein estimation by the product of integrated peak area and flow rate. Anal Biochem 182 (1989) 295-299
5. Chen H., Zhang Z., Chen Y., Brook M.A., and Sheardown H. Protein repellant silicone surfaces by covalent immobilization of poly(ethylene oxide). Biomaterials 26 (2005) 2391-2399
6. Cirioni O., Giacometti A., Ghiselli R., Bergnach C., Orlando F., Mocchegiani F., et al. Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. Peptides 27 (2006) 2104-2110
7. Cirioni O., Giacometti A., Ghiselli R., Kamysz W., Orlando F., Mocchegiani F., et al. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. Peptides 27 (2006) 1210-1216
8. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A6. Villanova, PA; 2003.
9. Cottagnoud P., Cottagnoud M., and Täuber M.G. Vancomycin acts synergistically with gentamicin against penicillin-resistant pneumococci by increasing the intracellular penetration of gentamicin. Antimicrob Agents Chemother 47 (2003) 144-147
10. Costerton J.W., Stewart P.S., and Greenberg E.P. Bacterial biofilm: a common cause of persistent infections. Science 284 (1999) 1318-1322
11. Donlan R.M., and Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15 (2002) 167-193
12. Edelhoch H. Spectroscopic determination of tryptophan and tyrosine in proteins. Biochemistry 6 (1967) 1948-1954
13. Eliopoulos G.M., and Moellering Jr. R.C. Antimicrobial combinations. In: Lorian V. (Ed). Antibiotics in laboratory medicine (1996), Williams & Wilkins, Baltimore, MD 330-393
14. Fux C.A., Costerton J.W., Stewart P.S., and Stoodley P. Survival strategies of infectious biofilm. Trends Microbiol 13 (2005) 34-40
15. Ghiselli R., Giacometti A., Cirioni O., Mocchegiani F., Orlando F., Bergnach C., et al. Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide. Peptides 27 (2006) 2592-2599
16. Hall-Stoodley L., Costerton J.W., and Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2 (2004) 95-108
17. Hancock R.E.W. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis 1 (2001) 156-164
18. Hancock R.E., and Sahl H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24 (2006) 1551-1557
19. Lojanapiwat B. Colonization of internal ureteral stent and bacteriuria. World J Urol 24 (2006) 681-683
20. Maki D.G. Infections caused by intravascular devices used for infusion therapy: pathogenesis, prevention and management. In: Bisno A.I., and Waldvogel F.A. (Eds). Infections associated with indwelling medical devices. 2nd ed. (2004), ASM Press, Washington, DC 155-212
21. McCafferty D.G., Cudic P., Yu M.K., Behenna D.C., and Kruger R. Synergy and duality in peptide antibiotic mechanisms. Curr Opin Chem Biol 3 (1999) 672-680
22. Raad I. Intravascular-catheter-related infection. Lancet 351 (1998) 893-898
23. Reid G., Denstedt J.D., Kang Y.S., Lam D., and Naus C. Microbial adhesion and biofilm formation on ureteral stents in vitro and in vivo. J Urol 148 (1992) 1592-1594
24. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 66 (2002) 236-248
25. Skerlavaj B., Gennaro R., Bagella L., Merluzzi L., Risso A., and Zanetti M. Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J Biol Chem 71 (1996) 28375-28381
26. Stepanovic S., Vukovic D., Dakic I., Savic B., and Svabic-Vlahovic M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods 40 (2000) 175-179
27. Tenke P., Kovacs B., Jäckel M., and Nagy E. The role of biofilm infection in urology. World J Urol 24 (2006) 13-20
28. Vaara M., and Porro M. Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria. Antimicrob Agents Chemother 40 (1996) 1801-1805
29. Yassien M., and Khardori N. Interaction between biofilms formed by Staphylococcus epidermidis and quinolones. Diagn Microbiol Infect Dis 40 (2001) 79-89
30. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75 (2004) 39-48
31. Zanetti M., Gennaro R., and Romeo D. Cathelicidins: a novel protein family with common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 374 (1995) 1-5